Syros Pharmaceuticals

Syros Pharmaceuticals company information, Employees & Contact Information

Updated June 2026

Quick answer

Syros Pharmaceuticals is a Pharmaceutical Manufacturing company and founded in 2012. It has approximately 30 employees on record. Contact data was last refreshed in June 2026. Find Syros Pharmaceuticals's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Syros was committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Company Details

Employees
30
Founded
2012
Address
Cambridge , Ma 02140, Us
Phone
(617) 744-1340
Email
In****@****ros.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
syros.com
HQ
Cambridge , MA
Looking for a particular Syros Pharmaceuticals employee's phone or email?

Syros Pharmaceuticals Questions

News

Failed Clinical Trial Forces Syros Pharmaceuticals Into Delisting and Wind-Down Operations - Stock Titan

Failed Clinical Trial Forces Syros Pharmaceuticals Into Delisting and Wind-Down Operations Stock Titan

Tamibarotene Plus Azacitidine Fails to Improve CR Rates in High-Risk, RARA+ MDS - OncLive

Tamibarotene Plus Azacitidine Fails to Improve CR Rates in High-Risk, RARA+ MDS OncLive

Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire

Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update Business Wire

Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7 - ACS Publications

Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7 ACS Publications

Flagship Pioneering Names Dr. Nancy Simonian, CEO of Syros, as Recipient of the 2019 Pioneering Leader Award - PR Newswire

Flagship Pioneering Names Dr. Nancy Simonian, CEO of Syros, as Recipient of the 2019 Pioneering Leader Award PR Newswire

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) FinancialContent

Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update - Business Wire

Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update Business Wire

Syros Reports Second Quarter 2024 Financial Results and Provides a Business Update - Stock Titan

Syros Reports Second Quarter 2024 Financial Results and Provides a Business Update Stock Titan

FDA Grants Fast Track Designation to Tamibarotene/Azacitidine/Venetoclax for RARA-Overexpressed AML - OncLive

FDA Grants Fast Track Designation to Tamibarotene/Azacitidine/Venetoclax for RARA-Overexpressed AML OncLive

Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants - Business Wire

Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants Business Wire

Top Syros Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant